Co-existent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH-translocations
Co-existent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH-translocations
The acquisition of the cytogenetic abnormalities hyperdiploidy or translocations into the immunoglobulin gene loci are considered as initiating events in the pathogenesis of myeloma and were often assumed to be mutually exclusive. These lesions have clinical significance with hyperdiploidy or the presence of the t(11;14) translocation associated with a favorable outcome whilst t(4;14), t(14;16) and t(14;20) are unfavorable. Poor outcomes are magnified when lesions occur in association with other high-risk features, del17p and +1q. Some patients have co-existence of both good and poor prognostic lesions and there has been no consensus on their risk status. To address this we have investigated their clinical impact using cases in the Myeloma IX study (ISRCTN68454111) and shown that the co-existence of hyperdiploidy or t(11;14) does not abrogate the poor prognosis associated with adverse molecular lesions, including translocations. We have also used single cell analysis to study cases with co-existent translocations and hyperdiploidy, to determine how these lesions co-segregate within the clonal substructure, and demonstrated that hyperdiploidy may precede IGH translocation in a proportion of patients. These findings have important clinical and biological implications as we conclude patients with coexistence of adverse lesions and hyperdiploidy should be considered high-risk and treated accordingly.
831-840
Pawlyn, C.
661fbdd4-0a5f-4bc6-a296-ef6a4fafd5bc
Melchor, L.
b6cf88d7-fe45-4f62-9247-22b9a991c84c
Murison, A.
a43db669-2fd4-436a-87cc-56f76f2275a7
Wardell, C.P.
4b4e2405-c2cc-48d8-ba35-5089891fa8ea
Brioli, A.
fd06eeb7-92c4-4724-b963-e7ef49b18616
Boyle, E.M.
0eccb492-30da-4118-a00f-9adb8fbfc7e1
Kaiser, M.F.
f0fdf0b2-156e-4d98-ae63-66f84cc3cb22
Walker, B.A.
d808cee3-7459-4d1a-af1a-be12674488a8
Begum, D.B.
a7174575-de0f-4eab-b56c-a455797a021f
Dahir, N.B.
b07305d5-c448-4292-a1c5-044c83f153ea
Proszek, P.
020fe916-1ae3-49ea-8348-e66c8bdcd5e1
Gregory, W.M.
cea7c53e-3baa-43af-89f2-94d783c3596f
Drayson, M.T.
6ec963b9-fbde-4f31-ab39-8ab12f74b902
Jackson, G.H.
2c9befc0-cbef-4b4c-81d8-a04766e23270
Ross, F.M.
ec0958f8-b992-4e4a-b7e3-c474600390ba
Davies, F.E.
3db5c54e-9852-4caf-91d9-8b339f68a632
Morgan, G.J.
7e5206cc-8a58-410c-9ea5-9022b1532ace
January 2015
Pawlyn, C.
661fbdd4-0a5f-4bc6-a296-ef6a4fafd5bc
Melchor, L.
b6cf88d7-fe45-4f62-9247-22b9a991c84c
Murison, A.
a43db669-2fd4-436a-87cc-56f76f2275a7
Wardell, C.P.
4b4e2405-c2cc-48d8-ba35-5089891fa8ea
Brioli, A.
fd06eeb7-92c4-4724-b963-e7ef49b18616
Boyle, E.M.
0eccb492-30da-4118-a00f-9adb8fbfc7e1
Kaiser, M.F.
f0fdf0b2-156e-4d98-ae63-66f84cc3cb22
Walker, B.A.
d808cee3-7459-4d1a-af1a-be12674488a8
Begum, D.B.
a7174575-de0f-4eab-b56c-a455797a021f
Dahir, N.B.
b07305d5-c448-4292-a1c5-044c83f153ea
Proszek, P.
020fe916-1ae3-49ea-8348-e66c8bdcd5e1
Gregory, W.M.
cea7c53e-3baa-43af-89f2-94d783c3596f
Drayson, M.T.
6ec963b9-fbde-4f31-ab39-8ab12f74b902
Jackson, G.H.
2c9befc0-cbef-4b4c-81d8-a04766e23270
Ross, F.M.
ec0958f8-b992-4e4a-b7e3-c474600390ba
Davies, F.E.
3db5c54e-9852-4caf-91d9-8b339f68a632
Morgan, G.J.
7e5206cc-8a58-410c-9ea5-9022b1532ace
Pawlyn, C., Melchor, L., Murison, A., Wardell, C.P., Brioli, A., Boyle, E.M., Kaiser, M.F., Walker, B.A., Begum, D.B., Dahir, N.B., Proszek, P., Gregory, W.M., Drayson, M.T., Jackson, G.H., Ross, F.M., Davies, F.E. and Morgan, G.J.
(2015)
Co-existent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH-translocations.
Blood, 125 (5), .
(doi:10.1182/blood-2014-07-584268).
(PMID:25428216)
Abstract
The acquisition of the cytogenetic abnormalities hyperdiploidy or translocations into the immunoglobulin gene loci are considered as initiating events in the pathogenesis of myeloma and were often assumed to be mutually exclusive. These lesions have clinical significance with hyperdiploidy or the presence of the t(11;14) translocation associated with a favorable outcome whilst t(4;14), t(14;16) and t(14;20) are unfavorable. Poor outcomes are magnified when lesions occur in association with other high-risk features, del17p and +1q. Some patients have co-existence of both good and poor prognostic lesions and there has been no consensus on their risk status. To address this we have investigated their clinical impact using cases in the Myeloma IX study (ISRCTN68454111) and shown that the co-existence of hyperdiploidy or t(11;14) does not abrogate the poor prognosis associated with adverse molecular lesions, including translocations. We have also used single cell analysis to study cases with co-existent translocations and hyperdiploidy, to determine how these lesions co-segregate within the clonal substructure, and demonstrated that hyperdiploidy may precede IGH translocation in a proportion of patients. These findings have important clinical and biological implications as we conclude patients with coexistence of adverse lesions and hyperdiploidy should be considered high-risk and treated accordingly.
This record has no associated files available for download.
More information
e-pub ahead of print date: 26 November 2014
Published date: January 2015
Organisations:
Human Development & Health
Identifiers
Local EPrints ID: 372664
URI: http://eprints.soton.ac.uk/id/eprint/372664
ISSN: 0006-4971
PURE UUID: aa94b2ba-824b-46eb-911a-b3a30f8544e5
Catalogue record
Date deposited: 17 Dec 2014 10:44
Last modified: 14 Mar 2024 18:40
Export record
Altmetrics
Contributors
Author:
C. Pawlyn
Author:
L. Melchor
Author:
A. Murison
Author:
C.P. Wardell
Author:
A. Brioli
Author:
E.M. Boyle
Author:
M.F. Kaiser
Author:
B.A. Walker
Author:
D.B. Begum
Author:
N.B. Dahir
Author:
P. Proszek
Author:
W.M. Gregory
Author:
M.T. Drayson
Author:
G.H. Jackson
Author:
F.M. Ross
Author:
F.E. Davies
Author:
G.J. Morgan
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics